SC 13G/A | 2022-02-14 | BALYASNY ASSET MANAGEMENT LLC | Dicerna Pharmaceuticals Inc | - | 0.0% | EDGAR |
SC 13G | 2021-12-03 | BALYASNY ASSET MANAGEMENT LLC | Dicerna Pharmaceuticals Inc | 4,408,952 | 5.7% | EDGAR |
SC 13G/A | 2021-02-12 | EcoR1 Capital, LLC | Dicerna Pharmaceuticals Inc | - | 0.0% | EDGAR |
SC 13G/A | 2021-02-12 | RTW INVESTMENTS, LP | Dicerna Pharmaceuticals Inc | 7,253,857 | 9.7% | EDGAR |
SC 13G | 2021-02-04 | WELLINGTON MANAGEMENT GROUP LLP | Dicerna Pharmaceuticals Inc | 4,317,623 | 5.8% | EDGAR |
SC 13G/A | 2021-01-29 | BlackRock Inc. | Dicerna Pharmaceuticals Inc | 6,034,729 | 8.0% | EDGAR |
SC 13D/A | 2020-12-14 | Bain Capital Life Sciences Fund, L.P. | Dicerna Pharmaceuticals Inc | 2,786,247 | 3.7% | EDGAR |
SC 13G/A | 2020-02-14 | Cormorant Asset Management, LP | Dicerna Pharmaceuticals Inc | 0 | - | EDGAR |
SC 13G/A | 2020-02-14 | EcoR1 Capital, LLC | Dicerna Pharmaceuticals Inc | 3,627,597 | 5.3% | EDGAR |
SC 13G/A | 2020-02-14 | BRIDGER MANAGEMENT, LLC | Dicerna Pharmaceuticals Inc | 1,981,633 | 2.9% | EDGAR |
SC 13G/A | 2020-02-14 | BRIDGER MANAGEMENT, LLC | Dicerna Pharmaceuticals Inc | 1,981,633 | 2.9% | EDGAR |
SC 13G/A | 2020-02-14 | RTW INVESTMENTS, LP | Dicerna Pharmaceuticals Inc | 5,874,229 | 8.6% | EDGAR |
SC 13G/A | 2020-02-05 | BlackRock Inc. | Dicerna Pharmaceuticals Inc | 4,433,090 | 6.5% | EDGAR |
SC 13D/A | 2019-12-06 | Bain Capital Life Sciences Fund, L.P. | Dicerna Pharmaceuticals Inc | 3,690,803 | 5.4% | EDGAR |
SC 13D/A | 2019-11-21 | Bain Capital Life Sciences Fund, L.P. | Dicerna Pharmaceuticals Inc | 5,047,637 | 7.4% | EDGAR |
SC 13D/A | 2019-05-31 | Bain Capital Life Sciences Fund, L.P. | Dicerna Pharmaceuticals Inc | 6,630,610 | 9.7% | EDGAR |
SC 13G/A | 2019-02-14 | Cormorant Asset Management, LP | Dicerna Pharmaceuticals Inc | 1,095,624 | - | EDGAR |
SC 13G/A | 2019-02-14 | EcoR1 Capital, LLC | Dicerna Pharmaceuticals Inc | 3,316,407 | 5.3% | EDGAR |
SC 13G/A | 2019-02-14 | BRIDGER MANAGEMENT, LLC | Dicerna Pharmaceuticals Inc | 4,773,718 | 7.6% | EDGAR |
SC 13G/A | 2019-02-14 | RTW INVESTMENTS, LP | Dicerna Pharmaceuticals Inc | 5,907,088 | 9.4% | EDGAR |